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Abstract
Restless legs syndrome (RLS) is a common neurologic disorder characterized by nightly dysesthesias affecting the legs
primarily during periods of rest and relieved by movement. RLS is a complex genetic disease and susceptibility factors in six
genomic regions have been identified by means of genome-wide association studies (GWAS). For some complex genetic
traits, expression quantitative trait loci (eQTLs) are enriched among trait-associated single nucleotide polymorphisms (SNPs).
With the aim of identifying new genetic susceptibility factors for RLS, we assessed the 332 best-associated SNPs from the
genome-wide phase of the to date largest RLS GWAS for cis-eQTL effects in peripheral blood from individuals of European
descent. In 740 individuals belonging to the KORA general population cohort, 52 cis-eQTLs with pnominal,10
23 were
identified, while in 976 individuals belonging to the SHIP-TREND general population study 53 cis-eQTLs with pnominal,10
23
were present. 23 of these cis-eQTLs overlapped between the two cohorts. Subsequently, the twelve of the 23 cis-eQTL SNPs,
which were not located at an already published RLS-associated locus, were tested for association in 2449 RLS cases and
1462 controls. The top SNP, located in the DET1 gene, was nominally significant (p,0.05) but did not withstand correction
for multiple testing (p = 0.42). Although a similar approach has been used successfully with regard to other complex
diseases, we were unable to identify new genetic susceptibility factor for RLS by adding this novel level of functional
assessment to RLS GWAS data.
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Introduction
Restless legs syndrome (RLS) is a common sensory-motor
disorder characterized by dysesthesias affecting the legs, triggered
by periods of rest, relieved by movement and occurring mostly
during the evening and at night. [1] Consequences are severe sleep
disturbances, depression, anxiety and possibly also increased
cardiovascular risk. [2,3] RLS is a complex polygenic phenotype
and genome-wide association studies (GWAS) have identified a
total of six genomic loci associated with the disease. [4–7] Still, the
susceptibility alleles known to date only explain about 6.8% of the
total heritability [6]. It is likely that additional risk loci of weaker
effect sizes exist that have not yet been ascertained in the GWAS.
It has been shown that single nucleotide polymorphisms (SNPs)
associated with complex genetic traits are more likely to have an
effect on gene expression and, thus, represent expression
quantitative trait loci (eQTLs). [8,9] The use of cis-eQTL analyses
in prioritizing sub-threshold association signals for GWAS follow-
up, has already been successfully employed with regard to several
complex diseases such as Crohn’s disease [10], asthma [11], or
schizophrenia [12]. Accordingly, we sought to prioritize sub-
threshold RLS association signals from an RLS GWAS [6] via cis-
eQTLs in the human blood for follow-up association study seeking
to highlight additional genetic factors involved in RLS.
Materials and Methods
Ethics Statement and Data Availability
The KORA and SHIP-TREND studies as well as the
recruitment of the RLS case/control sample was carried out in
accordance with the recommendations of the Declaration of
Helsinki and was approved by ethics committees of the
‘‘Bayerische Landesa¨rztekammer’’ and the Technische Universita¨t
Mu¨nchen (for KORA and the RLS case/control sample) and the
University of Greifswald (for SHIP-TREND). Written informed
consent was obtained from each of the study participants. Due to
ethics constraints, full expression and genotyping data sets cannot
be made available to the general public. However, interested




Study Design and SNP Selection
The objective of the study was to use blood-based cis-eQTL
analysis as a filter in the identification of new RLS susceptibility
factors from sub-threshold association signals from a previously
published GWAS. We selected all SNPs with an association signal
of pnominal,1610
23 (l-corrected, n= 332) from a recently
published RLS GWAS [7] for cis-eQTL analysis to identify SNPs
linked to differential mRNA expression (cis-eSNPs). These 332
SNPs represented 197 loci containing a single SNP and 101 loci
with two or more SNPs in very high linkage disequilibrium (LD;
r2$0.8). cis-eQTLs based on all 332 SNPs were identified in 740
individuals belonging to the KORA general population-based
study and, in parallel, in 976 individuals belonging to the SHIP-
TREND general population-based study. The cis-eSNPs with
pnominal,1610
23 present in both cohorts and not located at loci of
published association with RLS [4–7] were replicated in an
independent case/control sample (Figure 1) with the objective of
identifying new RLS-associated SNPs.
Cohorts and Case/Control Samples
KORA F4 cohort (discovery sample 1). Based in south-
western Germany, KORA (Cooperative Health Research in the
Region of Augsburg) is a regional research platform for
population-based surveys and follow-up studies. Whole-blood
samples used for expression analysis in this study were collected
from 740 subjects aged 62 to 81 years as part of the KORA F4
survey between 2006 and 2008 [13,14].
SHIP-TREND cohort (discovery sample 2). SHIP (Study
of Health in Pomerania in northeastern Germany) is a population-
based project consisting of two independent cohorts, SHIP and
SHIP-TREND [15,16]. For eQTL analysis, the SHIP-TREND
cohort was used where a total of 976 samples, from individuals
aged 20 to 81 years, with both imputed genotypes and whole-
blood gene expression data were available [16].
Case/control sample for eSNP association study. The
sample comprised 2449 German and Austrian individuals with
RLS (average age 48.0634.7 years, 70.7% female) and 1462
individuals belonging to the S4 survey of the KORA general
population cohort [17] (average age 49.9613.4 years, 51.7%
female), who were not genotyped in the genome-wide phase of the
GWAS [6]. Both case and control populations were entirely of
European descent. In all patients, diagnosis of primary RLS was
based on the diagnostic criteria of the International RLS Study
Group [1] as assessed in a personal interview conducted by an
RLS expert.
Genome-wide Genotyping (Discovery Samples 1 and 2)
As described previously [16,19], genome-wide genotyping of the
KORA sample was performed on Affymetrix Genome-Wide
Human SNP Arrays 6.0. SNPs with minor allele frequency (MAF)
,5%, a call rate ,98% or a significant deviation from Hardy-
Weinberg Equilibrium (HWE) (p,161025) were excluded.
Genotyping of the SHIP-TREND cohort has been described in
detail [16]. In short, participants of the SHIP-TREND cohorts
Figure 1. Study Design.
doi:10.1371/journal.pone.0098092.g001
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were genotyped using Illumina HumanOmni2.5-Quad arrays.
Arrays with a call rate below 94% as well as individuals with a
mismatch between the reported and genotyped sex were excluded.
Imputation of autosomal genotypes in the SHIP-TREND cohort
was performed using IMPUTE v2.1.2.3 [18] against the 1000
genomes phase I (interim) reference panel released June 2011 (all
ancestries panel, build 37).
Gene Expression Data and Quality Control (Discovery
Samples 1 and 2)
Sample selection and preparation of whole-blood gene expres-
sion analyses in KORA F4 and SHIP-TREND have been
described [16,19]. Briefly, in both studies blood was taken and
stored in PAXgene blood RNA tubes, RNA was isolated using the
PAXgene Blood miRNA Kit (Qiagen, Hilden, Germany) and
reverse transcribed using the Illumina TotalPrep-96 RNA Amp
Kit (Ambion, Darmstadt, Germany). The labelled cRNA was
hybridized to Illumina HumanHT-12 v3 Expression BeadChip
arrays and scanned using the Illumina Bead array reader. The
GenomeStudio v2010.1 Gene Expression Module was used for
quality control and to impute missing values. Subsequently, raw
gene expression intensities were exported from Illumina’s
GenomeStudio software to the R environment, where log2-
transformation and quantile normalization where carried out.
After quality control (exclusion of individuals with less than 6000
significantly detected probes (p,0.01) and individuals with a
reported vs. calculated gender mismatch), 740 KORA F4 and 976
SHIP-TREND samples with gene expression and genotype data
where available for analysis.
Determination of cis- and Trans-eQTLS
The eQTL analysis was carried out for all 332 selected sub-
threshold SNPs. For cis-eQTL analyses, all probes less than 500
kilobases (kb) away from the 332 selected SNP were used. Trans-
eQTLs were determined for all probes more than 5 megabases
(Mb) away from the SNP of interest.
Associations between the SNP and the respective mRNA probes
were analyzed using a linear model with adjustment for age and
sex. P-values were corrected using the Benjamini and Hochberg
procedure.
Genotyping of Replicated cis-eQTL SNPs in Case/Control
Replication Sample
Genotyping was performed on the MassARRAY system using
MALDI-TOF mass spectrometry with iPLEX Gold chemistry
(Sequenom Inc, San Diego, CA, USA). Genotypes were called
with SpectroTYPER 3.4. Genotype clustering was visually
checked by an experienced evaluator. SNPs with a call rate ,
95%, MAF ,5%, and Hardy-Weinberg p-value,161025 in
controls were excluded. Known RLS-associated SNPs were not
followed up in the replication. Associations were tested using the
allelic test as implemented in PLINK [20].
Analysis of Brain-derived cis-eQTLs
The brain cis-eQTL status of all 23 replicated cis-eSNPs was
analyzed using the NCBI GTEx eQTL browser (http://www.
ncbi.nlm.nih.gov/gtex/GTEX2/gtex.cgi, accessed August 5,
2012; expression data from cerebellum, frontal and temporal
cortex and pons, n = 142 to 144) [22] and the seeQTL browser
(http://gbrowse.csbio.unc.edu/cgi-bin/gb2/gbrowse/seeqtl/, ac-
cessed August 5, 2012; expression data from whole brain, n= 193)
[23].
Results
RLS-associated SNPs are more likely to be cis-eQTLs
To test whether RLS-associated SNPs are more commonly cis-
eQTLs than those not associated, we compared the number of cis-
eQTLs among the 332 most significantly associated SNPs (all with
pnominal,1610
23) from the latest RLS GWAS [6] to the 332 with
the worst association p-values. MAF distribution was similar in
both groups. Among the associated 332 SNPs, 52 cis-eQTLs
(pnominal,1610
23) were found while 37 cis-eQTLs were present
among the 332 not-associated SNPs. After very stringent LD
pruning (setting a threshold of r2#0.5), which was necessary as
there was significantly higher LD among the potentially associated
SNPs compared to the not associated SNPs, we found evidence for
an enrichment of cis-eQTLs (pnominal,1610
23) in the associated
vs. the not-associated SNPs (34 cis-eQTLs among 246 SNPs
harboring the most significant association signals vs. 28 cis-eQTLs
among 313 SNPs showing the least significant association signals;
Fisher’s exact test, one-sided, p,0.05, OR=1.63).
Analysis of Specific cis-eQTLs
Among the 332 best-associated SNPs, 52 cis-eSNPs with
pnominal,1610
23 resulting in 45 independent cis-eQTLs were
found when assessed in whole-blood samples from 740 KORA F4
controls. These 45 cis-eQTLs represent 33 loci with LD,0.8. Four
SNPs (intronic rs17487827 in BARD1 as well as intronic
rs6714954, rs7592599 and rs13387588 in SLC4A5) represented
cis-eQTLs of transcriptome-wide significance (pnominal,1610
28)
(Table 1). In the 976 SHIP-TREND samples, 59 cis-eSNPs with
pnominal,1610
23 resulting in 46 independent cis-eQTLs and 29
independent loci were identified (Table 1).
Of the six known RLS loci [5,6,7,8], only SNPs located on
chromosome15q were cis-eSNPs with pnominal,1610
23 in both
cohorts (Table 1). The expression change seen, however, did not
affect the primary candidate genes at these loci but rather another
gene in the vicinity.
Of the identified cis-SNPs, 23 overlapped between the KORA
and SHIP-TREND samples and eleven of these reached
transcriptome-wide significance in either cohort but only
rs17487827 in BARD1 reached transcriptome-wide significance
independently in both cohorts. The 23 replicated cis-eSNPs
contained nine that were dependent upon SNPs at the known
RLS-associated locus on chromosome 15q (MAP2K5/SKOR1).
None of these were associated with altered gene expression levels
of SKOR1 and only two cis-eSNPs (rs4489954 and rs28670272)
affected the gene expression levels of MAP2K5, the two candidate
genes underlying the GWAS association signal at this locus.
Instead, seven cis-eSNPs coincided with differential expression of
CALML4, located approximately 400 kb upstream of the known
locus.
The remaining 14 cis-eSNPs represented twelve individual loci
as three SNPs (rs7592599, rs6714954 and rs13387588) located in
SLC4A5 all associated with decreased expression levels of two
neighboring genes, AUP1 and MRPL53. Directions of differential
expression concurred in 42.9% (6 out of 14) of cis-eSNPs in the two
cohorts (Table 1).
Trans-eQTLs Linked to RLS-associated SNPs
We also assessed transcriptome-wide trans-eQTLs in the whole-
blood samples for 13 SNPs known to be associated with RLS [4–
7]. However, none of the trans-eQTLs identified in KORA F4 or
SHIP-TREND were also found at pnominal,1610
23 in the
respective other cohort (data not shown).
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Replication of Sub-threshold SNPs Representing cis-
eQTLs
Twelve cis-eSNPs with pnominal,10
23 in both the KORA F4
and the SHIP-TREND study were selected for replication in an
independent sample comprising 2449 German and Austrian RLS
cases and 1462 KORA general population-based controls. Due to
technical reasons, intergenic SNP rs6746899 could not be included
in the replication. One SNP in DET1 (rs9920066) showed
nominally significant association (pnominal,0.05) but did not
withstand Bonferroni correction (pcorrected = 0.42) while the other
ten SNPs were not associated with the RLS phenotype in the
replication sample (Table1).
Expression in Brain
The relevance of blood-based cis-eQTLs or cis-eSNPs to
neurologic and psychiatric diseases has been shown. [9] However,
differences between blood eQTLs or eSNPs and brain-based
eQTLs or eSNPs have also been demonstrated. [23] Therefore,
we analyzed the brain cis-eQTL status of all 23 cis-eSNPs seen in
both general population cohorts using the NCBI GTEx eQTL and
the seeQTL browsers. None of the 23 blood cis-eSNPs were also
cis-eSNPs with pnominal,1610
23 in the cerebellum, frontal and
temporal cortex or pons (n = 142 to 144) [22] or in whole brain
(n = 193) [23].
Discussion
Blood cis-eQTL analysis has been successfully used in enhancing
output from GWAS. [10,11,12] Here, we evaluated cis-eSNPs and
cis-eQTLs linked to (potential) RLS susceptibility genes identified
in previous RLS GWAS in order to prioritize sub-threshold
candidates for follow-up evaluation.
Apart from one SNP in the de-etiolated 1 encoding gene DET1
(rs9920066) that reached nominal significance in the replication
phase but did not withstand correction for multiple testing, we did
not identify any novel susceptibility factors for RLS.
Next to the possibility that eQTLs in general participate very
little in bringing about the RLS phenotype, it is possible that our
study lacks the power to establish an association between the RLS
phenotype and the SNPs underlying relevant eQTLs. Statistical
power calculation using the Purcell Power Calculator [24]
revealed that in order to replicate an association for one SNP
such as, for example, DET1 rs9920066 (OR=1.11 (95%
confidence interval: 1.00–1.22)), with MAF=0.30 at a =0.05,
one would need a minimum of 5,767 cases and 5,767 controls to
achieve 80% power.
Another caveat has to be that cis-eQTLs employed in selecting
SNPs for replication were evaluated in peripheral blood and not a
more disease-specific tissue. Although the underlying pathophys-
iology is not entirely clear, an involvement of the central nervous
system in RLS pathophysiology seems likely. Evaluation of the 23
common cis-eSNPs in two human brain expression data sets
showed that none of the blood cis-eQTLs were also found in the
brain. Whether this is due to the smaller number of samples (347
brain samples vs. 1716 blood samples) or the fact that cis-eQTLs
dependent on (potentially) RLS-associated SNPs in the peripheral
blood do not overlap with those in the brain and are not
functionally relevant for disease pathogenesis, remains unclear. It
is known that eQTLs can be specific to developmental time points
[22,23] and brain regions [21] and that they were, therefore, not
detected in the available data. In this context, an RLS-linked
common variant was recently shown to alter gene expression in the
murine ganglionic eminences, the primordial basal ganglia, during
development [25]. Accordingly, it will be of great interest to
evaluate eQTLs in specifically this neuroantomic region and at
this developmental time point in the future.
Although none of the RLS-associated SNPs selected for follow-
up could be replicated, two additional interesting aspects emerged.
Firstly, one of the known RLS susceptibility loci on chromosome
15q [4–6] comprising RLS candidate genes MAP2K5 and SKOR1
harbored nine cis-eSNPs with pnominal,1610
23. Two of these
showed altered MAP2K5 expression dependent on the RLS-risk
allele though in different directions in KORA F4 and SHIP-
TREND, while none were related to altered expression of SKOR1.
Interestingly, seven RLS-linked SNPs in MAP2K5 were further
related to altered expression of calmodulin-like 4 (CALML4), a
gene located approximately 400 kb upstream of the RLS-
associated MAP2K5/SKOR1 locus. However, here, too, the
direction of differential expression was not the same in both
cohorts. Despite the fact that several studies have been successful
in using cis-eQTLs to fine-map or provide functional support for
specific genes at a GWAS locus [11,26,27], in our study, the
situation is not as clear. It is possible that potential RLS-associated
expression changes in CALML4 are due to SNPs in CALML4,
which are in high LD with RLS-associated SNPs at the MAP2K5/
SKOR1 locus. Alternatively, it cannot be excluded that variation in
CALML4 instead of, or in addition to, MAP2K5/SKOR1 could play
a role in RLS pathogenesis, as has been postulated in other
complex traits such as the body mass index [28] or that these
expression changes are artificial as they do not concur in the two
cohorts.
Overall, we were unable to establish a new genetic susceptibility
factor for RLS, although, at least in the case of DET1, this may be
due to the lack of power to replicate alleles conferring only a small
risk increase. Our study is challenged by the fact that cis-eQTLs
were evaluated in peripheral blood and not a tissue of more
pathophysiologic relevance to RLS. In the future, as the
neuroanatomic correlates of RLS become more defined and more
expression profiles of different brain regions become available, it
will be interesting to assess whether the blood cis-eQTLs also play
a role in brain-region-specific, RLS-allele-dependent eQTLs and
in disease development.
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